DSM-5
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition |
|
---|---|
|
|
Author | American Psychiatric Association |
Language | English |
ISBN | 978-0-89042-554-1 |
Pages | 947 |
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) is the 2013 update to the Diagnostic and Statistical Manual of Mental Disorders, a taxonomic and diagnostic tool published by the American Psychiatric Association (APA). It serves as a key authority for psychiatric diagnoses in the United States, where it influences treatment recommendations and health care provider payments.[1]
History and Development[edit | edit source]
The DSM-5 was officially published on May 18, 2013, replacing the DSM-IV-TR, which was published in 2000. The process of developing the new edition began with a conference in 1999, followed by the formation of a Task Force in 2007, which developed and field-tested a variety of new classifications.[2]
Notable Changes[edit | edit source]
While the DSM-5 is not greatly modified from the DSM-IV-TR, there are some significant differences:
- The reconceptualization of Asperger syndrome from a distinct disorder to an autism spectrum disorder.
- The elimination of subtypes of schizophrenia.
- The deletion of the "bereavement exclusion" for depressive disorders.
- The renaming of gender identity disorder to gender dysphoria, along with a revised treatment plan.
- The inclusion of binge eating disorder as a discrete eating disorder.
- The renaming and reconceptualization of paraphilias to paraphilic disorders.
- The removal of the axis system.
- The splitting of disorders not otherwise specified into other specified disorders and unspecified disorders.[3]
Criticism and Controversy[edit | edit source]
The DSM-5 faced considerable criticism both before and after its formal publication. Critics argued that many DSM-5 revisions or additions lacked empirical support, inter-rater reliability was low for many disorders, and some sections contained poorly written, confusing, or contradictory information. There were also accusations of undue influence from the psychiatric drug industry, and conflicts of interest among work group members, including ties to pharmaceutical companies.[4] A petition signed by numerous mental health organizations called for an external review of the DSM-5.[5]
Impact[edit | edit source]
The DSM-5's changes had significant implications for diagnosis and treatment, including drug prescriptions and health insurance coverage. For example, the reclassification of Asperger syndrome as part of the autism spectrum could impact service eligibility for individuals previously diagnosed under the separate category.[6]
Future Directions[edit | edit source]
The APA has described DSM-5 as a "living document" and has established a process for ongoing revision, which will allow for more continuous integration of scientific findings.[7] This marks a departure from the previous static versions and offers an opportunity for more dynamic reflection of the evolving understanding of mental disorders.
See Also[edit | edit source]
- Diagnostic classification and rating scales used in psychiatry
- ICD-10 Chapter V: Mental and behavioural disorders
- Rosenhan experiment
- The Myth of Mental Illness
References[edit | edit source]
- ↑ "Diagnostic and Statistical Manual of Mental Disorders (DSM–5)". American Psychiatric Association. Retrieved 2023-05-03.
- ↑ "DSM-5: A Collection of Psychiatrist Views on the Changes, Controversies, and Future Directions". NCBI. Retrieved 2023-05-03.
- ↑ "Diagnostic and Statistical Manual of Mental Disorders (DSM–5)". American Psychiatric Association. Retrieved 2023-05-03.
- ↑ "DSM-5: A Collection of Psychiatrist Views on the Changes, Controversies, and Future Directions". NCBI. Retrieved 2023-05-03.
- ↑ "DSM-5 Is Guide Not Bible—Ignore Its Ten Worst Changes". Psychology Today. Retrieved 2023-05-03.
- ↑ "DSM-5: Frequently Asked Questions". Autism Speaks. Retrieved 2023-05-03.
- ↑ "Diagnostic and Statistical Manual of Mental Disorders (DSM–5)". American Psychiatric Association. Retrieved 2023-05-03.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD